Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Clinical Laboratory Tests Market to reach USD 194.3 billion by the end of 2029.

Global Clinical Laboratory Tests Market Size study & Forecast, by Type (Complete Blood Count, HGB/ HCT testing, Basic Metabolic Panel Testing, BUN Creatinine Testing, Electrolytes Testing, HbA1c Testing, Comprehensive Metabolic Panel Testing, Liver Panel Testing, Renal Panel Testing, Lipid Panel Testing, Cardiovascular Panel Tests), By End-Use (Central Laboratories, Primary Clinics), and Regional Analysis, 2022-2029

Product Code: HLSDT-29438038
Publish Date: 1-04-2023
Page: 200

Global Clinical Laboratory Tests Market is valued at approximately USD 94.7 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2022-2029. Clinical laboratory tests are medical tests that are performed on samples of blood, urine, other bodily fluids, or tissue in order to diagnose or monitor a wide range of health conditions and diseases. These tests can provide information about a person’s overall health, as well as specific conditions such as infections, cancers, and genetic disorders. The market demand is primarily driven by the factors such as the global population ages, the demand for clinical laboratory tests is expected to increase, as older adults are more likely to develop age-related diseases and conditions that require diagnostic testing, coupled with Governments around the world have been investing in healthcare infrastructure and promoting healthcare access for their citizens. This has led to an increased demand for clinical laboratory tests, as more people are able to access healthcare services and are diagnosed with diseases that require laboratory testing.

In addition, the global burden of chronic diseases, such as diabetes, cardiovascular disease, and cancer, is increasing, driving demand for clinical laboratory tests to diagnose, monitor, and manage these conditions are acting as major driving factors for market growth. According to World Health Organization, Non-communicable diseases (NCDs) account for 41 million annual fatalities, or 71% of all fatalities worldwide. Between the ages of 30 and 69, more than 15 million people per year pass away from an NCD; 85% of these “premature” deaths take place in low- and middle-income nations. The majority of NCD deaths, or 17.9 million people per year, are caused by cardiovascular diseases, followed by malignancies (9.3 million), respiratory illnesses (4.1 million), and diabetes (1.5 million). Almost 80% of all NCD-related deaths that occur prematurely are caused by these four disease types, thus, in turn, these factors are expected to escalate the demand for Clinical Laboratory Tests in the global market. Furthermore, the adoption and development of data management and informatics solutions to support efficient operations, as well as recent advancements in technology are presenting lucrative opportunities for market growth over the forthcoming years. However, the ambiguous regulatory framework is restricting the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Clinical Laboratory Tests Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the widespread use of several medications as well as for regional biotechnology businesses. The region market may also be driven by rising technological innovation, and as the elderly population grows, so does the demand for diagnostic tools. Whereas, Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as increasing investment in the research and development sector and the healthcare sector are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
Quest Diagnostics
Abbott Laboratories
NeoGenomics Laboratories Inc.
Laboratory Corporation of America Holdings
ARUP Laboratories
OPKO Health, Inc.
UNILABS
Clinical Reference Laboratory, Inc.
Synnovis Group LLP
Sonic Healthcare Limited.

Recent Developments in the Market:
 In March 2023, OPKO Health, Inc. stated that ModeX Therapeutics, Inc., a subsidiary of OPKO Health, had signed an exclusive licence and partnership agreement for the development of MDX-2201, ModeX’s preclinical nanoparticle vaccine candidate for EBV, with Merck, also known as MSD outside of the United States and Canada.
 In February 2023, Unilabs, a prominent diagnostic services provider, and Siemens Healthineers, a leading medical technology business, announced a multi-year agreement. Unilabs has made a significant investment in the cutting-edge technology of Siemens Healthineers and will buy more than 400 laboratory analyzers to further enhance its laboratory infrastructure and provide its clients with unmatched service.
 In February 2023, Abbott Laboratories and Cardiovascular Systems, Inc. (CSI) signed a definitive agreement for Abbott to purchase CSI, a medical device business with a novel atherectomy system utilised in the treatment of peripheral and coronary artery disease. With the acquisition of CSI, Abbott’s market-leading vascular device lineup will now include new, complementary technologies.
 In November 2022, NeoGenomics, Inc. (NASDAQ:NEO), a company that provides of oncology testing and global contract research services, announced the launch of a novel biomarker testing programme for patients with epithelial ovarian cancer, including primary peritoneal or fallopian tube tumours (EOC). EOC patients will have access to the FOLR1 IHC CDx test (VENTANA FOLR1 RxDx Assay), carried out by NeoGenomics to assess the expression of a protein known as folate receptor alpha (FR), under the FR-ASSISTTM initiative, sponsored by ImmunoGen, Inc.

Global Clinical Laboratory Tests Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End-Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Complete Blood Count
HGB/ HCT testing
Basic Metabolic Panel Testing
BUN Creatinine Testing
Electrolytes Testing
HbA1c Testing
Comprehensive Metabolic Panel Testing
Liver Panel Testing
Renal Panel Testing
Lipid Panel Testing
Cardiovascular Panel Tests

By End-Use:
Central Laboratories
Primary Clinics

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Clinical Laboratory Tests Market, by Region, 2019-2029 (USD Billion)
1.2.2. Clinical Laboratory Tests Market, by Type, 2019-2029 (USD Billion)
1.2.3. Clinical Laboratory Tests Market, by End-Use, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Laboratory Tests Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Laboratory Tests Market Dynamics
3.1. Clinical Laboratory Tests Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Growing geriatric population.
3.1.1.2. Government initiatives to promote healthcare.
3.1.1.3. Increasing prevalence of chronic and infectious diseases.
3.1.2. Market Challenges
3.1.2.1. Ambiguous regulatory framework.
3.1.3. Market Opportunities
3.1.3.1. Development of data management and informatics solutions.
3.1.3.2. Recent advancements in technology.
Chapter 4. Global Clinical Laboratory Tests Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Clinical Laboratory Tests Market, by Type
6.1. Market Snapshot
6.2. Global Clinical Laboratory Tests Market by Type, Performance – Potential Analysis
6.3. Global Clinical Laboratory Tests Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Clinical Laboratory Tests Market, Sub Segment Analysis
6.4.1. Complete Blood Count
6.4.2. HGB/ HCT testing
6.4.3. Basic Metabolic Panel Testing
6.4.4. BUN Creatinine Testing
6.4.5. Electrolytes Testing
6.4.6. HbA1c Testing
6.4.7. Comprehensive Metabolic Panel Testing
6.4.8. Liver Panel Testing
6.4.9. Renal Panel Testing
6.4.10. Lipid Panel Testing
6.4.11. Cardiovascular Panel Tests
Chapter 7. Global Clinical Laboratory Tests Market, by End-Use
7.1. Market Snapshot
7.2. Global Clinical Laboratory Tests Market by End-Use, Performance – Potential Analysis
7.3. Global Clinical Laboratory Tests Market Estimates & Forecasts by End-Use 2019-2029 (USD Billion)
7.4. Clinical Laboratory Tests Market, Sub Segment Analysis
7.4.1. Central Laboratories
7.4.2. Primary Clinics
Chapter 8. Global Clinical Laboratory Tests Market, Regional Analysis
8.1. Clinical Laboratory Tests Market, Regional Market Snapshot
8.2. North America Clinical Laboratory Tests Market
8.2.1. U.S. Clinical Laboratory Tests Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End-Use breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Clinical Laboratory Tests Market
8.3. Europe Clinical Laboratory Tests Market Snapshot
8.3.1. U.K. Clinical Laboratory Tests Market
8.3.2. Germany Clinical Laboratory Tests Market
8.3.3. France Clinical Laboratory Tests Market
8.3.4. Spain Clinical Laboratory Tests Market
8.3.5. Italy Clinical Laboratory Tests Market
8.3.6. Rest of Europe Clinical Laboratory Tests Market
8.4. Asia-Pacific Clinical Laboratory Tests Market Snapshot
8.4.1. China Clinical Laboratory Tests Market
8.4.2. India Clinical Laboratory Tests Market
8.4.3. Japan Clinical Laboratory Tests Market
8.4.4. Australia Clinical Laboratory Tests Market
8.4.5. South Korea Clinical Laboratory Tests Market
8.4.6. Rest of Asia Pacific Clinical Laboratory Tests Market
8.5. Latin America Clinical Laboratory Tests Market Snapshot
8.5.1. Brazil Clinical Laboratory Tests Market
8.5.2. Mexico Clinical Laboratory Tests Market
8.5.3. Rest of Latin America Clinical Laboratory Tests Market
8.6. Rest of The World Clinical Laboratory Tests Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Quest Diagnostics
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Abbott Laboratories
9.2.3. NeoGenomics Laboratories Inc.
9.2.4. Laboratory Corporation of America Holdings
9.2.5. ARUP Laboratories
9.2.6. OPKO Health, Inc.
9.2.7. UNILABS
9.2.8. Clinical Reference Laboratory, Inc.
9.2.9. Synnovis Group LLP
9.2.10. Sonic Healthcare Limited.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now